Search hospitals
>
Quebec
>
MONTREAL
Maisonneuve-Rosemont Hospital
Claim this profile
MONTREAL, Quebec H1T 2M4
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Acute Myeloid Leukemia
Conducts research for Leukemia
Conducts research for Colorectal Cancer
317 reported clinical trials
26 medical researchers
Summary
Maisonneuve-Rosemont Hospital is a medical facility located in MONTREAL, Quebec. This center is recognized for care of Breast Cancer, Cancer, Acute Myeloid Leukemia, Leukemia, Colorectal Cancer and other specialties. Maisonneuve-Rosemont Hospital is involved with conducting 317 clinical trials across 475 conditions. There are 26 research doctors associated with this hospital, such as Michael Yassa, Jonathan Noujaim, Dr. Mai-Kim Gervais, and Veronique Brulotte, MD, MSc.
Area of expertise
Breast Cancer
Maisonneuve-Rosemont Hospital has run 29 trials for Breast Cancer. Some of their research focus areas include:
Cancer
Maisonneuve-Rosemont Hospital has run 28 trials for Cancer. Some of their research focus areas include:
Top PIs
Michael Yassa
Maisonneuve-Rosemont Hospital
2 years of reported clinical research
Jonathan Noujaim
GSK Investigational Site
2 years of reported clinical research
Dr. Mai-Kim Gervais
Hopital Maisonneuve Rosemont
5 years of reported clinical research
Veronique Brulotte, MD, MSc
Maisonneuve-Rosemont Hospital
11 years of reported clinical research
Clinical Trials running at Maisonneuve-Rosemont Hospital
Acute Myeloid Leukemia
Prostate Cancer
Breast Cancer
Cancer
Ovarian Cancer
Acute Lymphoblastic Leukemia
Leukemia
Acute Leukemia
Chronic Renal Failure
Cardiovascular Disease
Combination Therapies
for Acute Myeloid Leukemia
This phase II MyeloMATCH treatment trial compares cytarabine with daunorubicin versus cytarabine with daunorubicin and venetoclax versus venetoclax with azacitidine for the treatment of younger patients with intermediate risk acute myeloid leukemia (AML). Cytarabine is a drug that inhibits some of the enzymes needed for deoxyribonucleic acid (DNA) replication and repair and can slow or stop the growth of cancer cells. Daunorubicin is a drug that blocks a certain enzyme needed for cell division and DNA repair, and it may kill cancer cells. Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Azacitidine is a drug that interacts with DNA to activate tumor-suppressing genes, resulting in an anti-tumor effect. Adding venetoclax to cytarabine and daunorubicin, and adding venetoclax to azacitidine, may work better than the usual treatment of cytarabine with daunorubicin alone. To decide if they are better, the study doctors are looking to see if venetoclax increases the rate of elimination of AML in participants by 20% or more compared to the usual approach.
Recruiting
1 award
Phase 2
6 criteria
JNJ-75276617
for Acute Leukemia
This trial tests JNJ-75276617, an oral drug designed to block a protein interaction that helps leukemia cells grow. It targets patients with specific genetic types of AML or ALL. By stopping these proteins from working together, the drug aims to slow down or stop cancer cell growth.
Recruiting
1 award
Phase 1 & 2
6 criteria
Ziftomenib
for Relapsed/Refractory Acute Myeloid Leukemia
This trial is testing ziftomenib, a new drug, in patients with difficult-to-treat acute myeloid leukemia (AML). The drug works by blocking a protein interaction that cancer cells need to grow.
Recruiting
1 award
Phase 1 & 2
9 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Maisonneuve-Rosemont Hospital?
Maisonneuve-Rosemont Hospital is a medical facility located in MONTREAL, Quebec. This center is recognized for care of Breast Cancer, Cancer, Acute Myeloid Leukemia, Leukemia, Colorectal Cancer and other specialties. Maisonneuve-Rosemont Hospital is involved with conducting 317 clinical trials across 475 conditions. There are 26 research doctors associated with this hospital, such as Michael Yassa, Jonathan Noujaim, Dr. Mai-Kim Gervais, and Veronique Brulotte, MD, MSc.
Where is Maisonneuve-Rosemont Hospital located?
**Maisonneuve-Rosemont Hospital** - **Address:** 5415 Boulevard de l'Assomption, Montreal, Quebec. - **Accessibility:** The hospital is about a 13-minute walk from Station Viau, the nearest metro station.
Who should I call to ask about financial aid or insurance network?
**Maisonneuve-Rosemont Hospital Financial and Insurance Services** **Financial Services:** - CIUSSS EMTL - Exclusifs benefits - Financial services - Beneva **Insurance and Financial Services:** - Agency: Montréal Maisonneuve, iA Financial Group - Location: 6555 Métropolitain Blvd. E, Unit 403, Saint-Léonard, Quebec, H1P 3H3 - Contact: 514-324-3811, Toll-free: 1-866-324-3811, Fax: 1-877-781-7413 - Hours: Mon-Fri, 8:30 am - 4:30 pm **Public Health Insurance and Prescription Drug Insurance Plans:** - Provider: Régie de l'assurance maladie du Québec (RAMQ) - Contact: Québec: 418 646-4636, Montréal: 514 864-3411, Toll-free: 1 800 561-9749, Outside Québec: 514 864-3411 - Hours: Mon-Fri, 8:30 am - 4:30 pm
What insurance does Maisonneuve-Rosemont Hospital accept?
Maisonneuve-Rosemont Hospital is part of the Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l’Est-de-l’Île-de-Montréal. It is affiliated with Université de Montréal and welcomes over 4,000 students annually. For detailed information about accepted insurance plans, it is recommended to contact the hospital directly or visit their official website.
What awards or recognition has Maisonneuve-Rosemont Hospital received?
Maisonneuve-Rosemont Hospital, located in Montreal, Quebec, is renowned for its excellence in immunology-oncology, nephrology, and vision health. Its research center, CR-HMR, is globally recognized for pioneering clinical therapies and vibrant academic endeavors. The hospital leads in cellular therapy, innovating treatments for incurable diseases within its areas of excellence.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.